Search
for
Sort by
Research 961–990 of 1000+
- Nutrition and the deleterious side effects of nutritional supplements
- Alopecia Areata
- Does the Recipient Site Influence the Hair Growth Characteristics in Hair Transplantation?
- Contraceptive implant use among inner city teens
- Alterations in androgen conjugate levels in women and men with alopecia
- Hair Loss in Systemic Disease
- AMINOPTERIN IN TREATMENT OF LEUKEMIA IN CHILDREN
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Contraception and the dermatologist
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Alopecia.
- PTCH1 Germline Mutations and the Basaloid Follicular Hamartoma Values in the Tumor Spectrum of Basal Cell Carcinoma Syndrome (NBCCS)
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- The pathophysiology of delayed ejaculation
- Defining the identity of mouse embryonic dermal fibroblasts
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Alopecia in Epidermolysis Bullosa
- Stress and the skin: Significance of emotional factors in dermatology
- Ashy Dermatosis
- An Update on Drug-Induced Pigmentation
- Psychosomatic aspects of alopecia areata
- Secondary cicatricial and other permanent alopecias
- Antiandrogen Therapy for Skin and Hair Disease
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Effect of Surface Treatments on the Nanomechanical Properties of Human Hair
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Telogen Effluvium: Is There a Need for a New Classification
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE